Paul Offit of the Perelman School of Medicine wrote an opinion piece about the human cost of conducting child vaccine trials. While some may be concerned that the Pfizer trial was too small or too brief, Offit argued that a larger or longer trial would have resulted in more sick children in the placebo group, as occurred during the polio vaccine’s development.